Evidence map›Paper›PMID 23147374›Full record

ArticleEuropean journal of immunology2013

Relationship between chemokine receptor expression, chemokine levels and HIV-1 replication in the lungs of persons exposed to Mycobacterium tuberculosis.

Barbara Kalsdorf, Keira H Skolimowska, Thomas J Scriba, Rod Dawson, Keertan Dheda, Kathryn Wood, Jessica Hofmeister, Willem A Hanekom, Christoph Lange, Robert J Wilkinson

Open access · hybridAbstract read
In one paragraph

Article in European journal of immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in immunology · 2020
    Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Barbara KalsdorfClinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa. bkalsdorf@fz-borstel.de
Keira H Skolimowska
Thomas J Scriba
Rod Dawson
Keertan Dheda
Kathryn Wood
Jessica Hofmeister
Willem A Hanekom
Christoph Lange
Robert J Wilkinson
University of Cape Town · ZASouth African Tuberculosis Vaccine Initiative · ZAWellcome Centre for Infectious Diseases Research in Africa · ZAImperial College London · GBResearch Center Borstel - Leibniz Lung Center · DETechnical University of Applied Sciences Lübeck · DE

Funding

Host determinants of protection against tuberculosis in adolescentsR01AI087915 · NIAID · UNIVERSITY OF CAPE TOWN · PI SCRIBA, THOMAS JENS · 2011 to 2015
$3.3M
Protective immunity induced by newborn BCG vaccinationR01AI065653 · NIAID · UNIVERSITY OF CAPE TOWN · PI HANEKOM, WILLEM ALBERT · 2005 to 2009
$2.5M
Medical Research Council MC_U117588499Medical Research Council U.1175.02.002.00014.01NIAID NIH HHS N01 AI070022NIAID NIH HHS N01-AI-70022NIAID NIH HHS R01 AI065653NIAID NIH HHS R01 AI087915NIAID NIH HHS R01-AI-087915Wellcome TrustWellcome Trust 080929Wellcome Trust 084323Wellcome Trust 088316
6 · The paper itself

Abstract

Increased susceptibility to tuberculosis following HIV-1 seroconversion contributes significantly to the tuberculosis epidemic in sub-Saharan Africa. Lung-specific mechanisms underlying the interaction between HIV-1 and Mycobacterium tuberculosis infection are incompletely understood. Here we address these questions by examining the effect of HIV-1 and latent M. tuberculosis co-infection on the expression of viral-entry receptors and ligands in bronchoalveolar lavage (BAL) of HIV-1-infected and -uninfected patients with and without latent M. tuberculosis infection. Irrespective of HIV-1 status, T cells from BAL expressed higher levels of the beta-chemokine receptor (CCR)5 than peripheral blood T cells, in particular the CD8(+) T cells of HIV-1-infected persons showed elevated CCR5 expression. The concentrations of the CCR5 ligands RANTES and MIP-1β were elevated in the BAL of HIV-1-infected persons compared with that in HIV-1-uninfected controls. CCR5 expression and RANTES concentration correlated strongly with HIV-1 viral load in the BAL. In contrast, these alterations were not associated with M. tuberculosis sensitisation in vivo, nor did M. tuberculosis infection of BAL cells ex vivo change RANTES expression. These data suggest ongoing HIV-1 replication predominantly drives local pulmonary CCR5(+) T-cell activation in HIV/latent M. tuberculosis co-infection.

Indexed as

AdultAfrica South of the SaharaBronchoalveolar LavageCD8-Positive T-LymphocytesChemokine CCL4Chemokine CCL5ChemokinesCoinfectionFemaleHIV-1HIV InfectionsHumansLigandsLungMaleMiddle AgedCCL5 protein, humanChemokine CCL4Chemokine CCL5ChemokinesLigandsReceptors, CCR5Receptors, Chemokine

Identifiers

PMID23147374
PMCPMC3791514
OpenAlexW1596100394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.